Neither NICE nor the MHRA has issued guidance recommending retatrutide, as it remains unlicensed
However, there was no difference in the IVF PR (RR: 1.06, 95% CI 0.69 to 1.64, I 2 = 8.3%, P = 0.791) or total PR (RR: 1.35, 95% CI 0.96 to 1.91, I 2 = 40.7%, P = 0.087)
--- Practical Stack Examples Recovery-Focused (injuries, training stress) BPC-157: 250mcg subQ daily KLOW: per protocol NMN: 500mg oral AM GHK-Cu: 12mg subQ daily Longevity + Performance (40+) MOTS-C: 500mcg subQ daily NMN or NR: 500mg oral AM Tesamorelin: 12mg subQ AM (optional, for visceral fat + GH axis support) GHK-Cu: 1mg subQ daily Metabolic Recomp (on Reta or Tirz) Retatrutide: per titration protocol NMN: 250500mg daily MOTS-C: 500mcg daily (complement to GLP-1 for fat oxidation) BPC-157: 250mcg as needed for any GI irritation or connective tissue support --- Frequently Asked Questions Q: Can I take NMN and NR together
Protocols examining GH deficiency models, age-related GH decline, and hypothalamic-pituitary axis integrity use both GHRH and ghrelin receptor agonism together to characterize the full secretory capacity of the pituitary
I have a patient in Arizona who isnt obese